NatureWise Biotech & Medicals Corporation (TPEX:4732)
16.60
+0.30 (1.84%)
Aug 4, 2026, 1:00 PM CST
TPEX:4732 Market Cap
TPEX:4732 has a market cap or net worth of 762.33 million as of August 4, 2026. Its market cap has decreased by -30.30% in one year.
Market Cap
762.33M
Enterprise Value
319.86M
Revenue
176.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.60
ChartMarket Cap Chart
Since December 25, 2007, TPEX:4732's market cap has increased from 285.93M to 762.33M, an increase of 166.62%. That is a compound annual growth rate of 5.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 762.33M | -23.76% |
| Dec 31, 2025 | 999.93M | -18.70% |
| Dec 31, 2024 | 1.23B | -8.42% |
| Dec 29, 2023 | 1.34B | -22.70% |
| Dec 30, 2022 | 1.74B | -31.42% |
| Dec 30, 2021 | 2.53B | 109.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |
| Holy Stone Healthcare | 912.34M |
| TCI GENE | 899.59M |
| Meribank Biotech | 872.42M |
| Taiwan Advance Bio-Pharmaceutical | 808.20M |
| BioLASCO Taiwan | 799.09M |
| Neith | 710.20M |